Life on the Edge – Filling the LS Revenue Gap on a Throw of the Dice

By Dr. Alan S. Louie – December 11, 2009
Photo of Dr. Alan S. LouieOffline

The life science industry continues to move forward as it tries desperately to fill expected loss of revenue from drug blockbusters over the next several years.  Major M&A between mega pharmaceutical companies promises to restore profitability through increased operational efficiency, although this approach can only hope to maintain a somewhat proportionate rate of return at a lower combined revenue level.  Acquisitions of smaller biotechnology companies are a higher risk bet on the success of


About the author

Dr. Alan S. Louie

Research DirectorIDC Health Insights

Dr. Alan Louie is Research Director at IDC Health Insights. In this role, he is spearheading the company’s research covering innovation and best practices in pharmaceutical R&D and personalized…


Post a comment

Form Signatures

Viewed 1,118 times